Paul Moss

University Hospitals Birmingham NHS Foundation Trust — United Kingdom

Immunology and Microbiology · Life Sciences

84h-index31.6kcitations578works5.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immune Cell Function and Interaction(140), Cytomegalovirus and herpesvirus research(115), T-cell and B-cell Immunology(108), SARS-CoV-2 and COVID-19 Research(83), Chronic Lymphocytic Leukemia Research(72)

Publications567 total

Endemic penetrance of SARS-CoV-2 has impacted marginally on immunity to spike protein of human coronaviruses
Communications Biology·2026Open Access
CORE - A Cell-Level Coarse-to-Fine Image Registration Engine for Multi-stain Image Alignment
SSRN Electronic Journal·2026Open Access
Robust Adaptive Immunity to MPXV in Older People Who Received Childhood Vaccinia Vaccination
ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam)·2026Open Access
Valaciclovir therapy for secondary suppression of immune response to herpesviruses: An exploratory study
PLoS Pathogens·2025Open Access
307 Baseline Gut Microbiome Composition is Associated with Response to Neoadjuvant Chemotherapy in Pancreatic Cancer Patients
British journal of surgery·2025Open Access
Figure 5 from Tissue-Resident Memory T Cells in Pancreatic Ductal Adenocarcinoma Coexpress PD-1 and TIGIT and Functional Inhibition Is Reversible by Dual Antibody Blockade
2025Open Access
Figure 3 from Tissue-Resident Memory T Cells in Pancreatic Ductal Adenocarcinoma Coexpress PD-1 and TIGIT and Functional Inhibition Is Reversible by Dual Antibody Blockade
2025Open Access
Figure 4 from Tissue-Resident Memory T Cells in Pancreatic Ductal Adenocarcinoma Coexpress PD-1 and TIGIT and Functional Inhibition Is Reversible by Dual Antibody Blockade
2025Open Access
Figure 6 from Tissue-Resident Memory T Cells in Pancreatic Ductal Adenocarcinoma Coexpress PD-1 and TIGIT and Functional Inhibition Is Reversible by Dual Antibody Blockade
2025Open Access
Figure 2 from Tissue-Resident Memory T Cells in Pancreatic Ductal Adenocarcinoma Coexpress PD-1 and TIGIT and Functional Inhibition Is Reversible by Dual Antibody Blockade
2025Open Access
Supplementary Fig. S1 - S12 from Tissue-Resident Memory T Cells in Pancreatic Ductal Adenocarcinoma Coexpress PD-1 and TIGIT and Functional Inhibition Is Reversible by Dual Antibody Blockade
2025Open Access
Supplementary Tables S1 - S5 from Tissue-Resident Memory T Cells in Pancreatic Ductal Adenocarcinoma Coexpress PD-1 and TIGIT and Functional Inhibition Is Reversible by Dual Antibody Blockade
2025Open Access
Figure 1 from Tissue-Resident Memory T Cells in Pancreatic Ductal Adenocarcinoma Coexpress PD-1 and TIGIT and Functional Inhibition Is Reversible by Dual Antibody Blockade
2025Open Access
CORE -- A Cell-Level Coarse-to-Fine Image Registration Engine for Multi-stain Image Alignment
arXiv (Cornell University)·2025Open Access
Establishing biological variation of immunological and inflammatory biomarkers in healthy individuals: a longitudinal study
Journal of Immunological Methods·2025
A-141 Biological variation of soluble B-cell maturation antigen in healthy donors
Clinical Chemistry·2025Open Access
Observing the cancer microenvironment in mycosis fungoides following immune checkpoint blockade
European Journal of Cancer·2025
COVID-19 burden of illness in people who are immunocompromised due to cancer: an expert opinion review
The Oncologist·2025· 1 citedOpen Access
The impact of pausing Bruton Tyrosine Kinase inhibitor (BTKi) therapy versus continued therapy on vaccination immune response in patients with chronic lymphocytic leukaemia: the IMPROVE RCT
Efficacy and Mechanism Evaluation·2025Open Access
Phase II trial of atezolizumab (Anti-PD-L1) in the treatment of relapsed/refractory IIB/IVB mycosis fungoides/Sézary syndrome patients after previous systemic treatment. EORTC-1652-CLTG “PARCT”
European Journal of Cancer·2025· 5 citedOpen Access
page 1 of 29Next →

Frequent Co-authors

Naeem Khan(9), John I. Bell(8), Tatjana Stanković(7), Laxman Nayak(6), Charles Craddock(6), Andrew J. McMichael(5), Mark Cobbold(5), A. Malcolm R. Taylor(5), Alan B. Rickinson(4), Ronjon Chakraverty(4), Rachel Bruton(3), Geraldine M. Gillespie(3), Premini Mahendra(3), Chris Fegan(3), Sarah Rowland‐Jones(3), Angelo Agathanggelou(3), Oliver Goodyear(3), Guy Pratt(3), William Rosenberg(3), Arne N. Akbar(3)